Anosmia, also known as smell blindness, is the loss of the ability to detect one or more smells. Anosmia may be temporary or permanent. It differs from hyposmia, which is a decreased sensitivity to some or all smells.
This report contains market size and forecasts of Anosmia in Global, including the following market information:
Global Anosmia Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Anosmia market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Therapies Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Anosmia include Mylan N.V, Pfizer Inc, Atom Pharma, RANBAXY LABORATORIES LIMITED, Alde Medi Impex, GlaxoSmithkline Plc, Sandoz (Novasrtis AG), Inke S.A. and Taj Pharmaceuticals Limited and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Anosmia companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anosmia Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Anosmia Market Segment Percentages, by Type, 2021 (%)
Therapies
Medications
Global Anosmia Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Anosmia Market Segment Percentages, by Application, 2021 (%)
Idiopathic Anosmia
Congenital Anosmia
Global Anosmia Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Anosmia Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anosmia revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Anosmia revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Mylan N.V
Pfizer Inc
Atom Pharma
RANBAXY LABORATORIES LIMITED
Alde Medi Impex
GlaxoSmithkline Plc
Sandoz (Novasrtis AG)
Inke S.A.
Taj Pharmaceuticals Limited
Sanofi